Han Zhu

300 Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Analysis of risk factors for relapse after allogeneic hematopoietic stem cell transplantation in acute leukemia.

Analysis of risk factors for relapse after allogeneic hematopoietic stem cell transplantation in acute leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: July 22, 2025

Impact of HLA locus mismatch on peripheral blood allogeneic hematopoietic stem cell transplantation from unrelated donors using an ATG-based GVHD prophylaxis strategy.

Impact of HLA locus mismatch on peripheral blood allogeneic hematopoietic stem cell transplantation from unrelated donors using an ATG-based GVHD prophylaxis strategy.

Journal: Blood research

Published: February 17, 2025

LRRFIP1 enhances the Wnt/β-catenin pathway by binding to DVLs in myelodysplastic syndrome.

LRRFIP1 enhances the Wnt/β-catenin pathway by binding to DVLs in myelodysplastic syndrome.

Journal: Journal of translational medicine

Published: December 14, 2024

Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world study.

Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world study.

Journal: International journal of cancer

Published: October 10, 2024

A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study.

A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study.

Journal: Bone marrow transplantation

Published: July 06, 2024

The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation.

The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation.

Journal: British journal of haematology

Published: March 14, 2024

Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report.

Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report.

Journal: Annals of hematology

Published: February 27, 2024

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study.

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study.

Journal: EJHaem

Published: January 20, 2024

Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML.

Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML.

Journal: American journal of hematology

Published: March 28, 2023

Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention.

Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention.

Journal: Bone marrow transplantation

Published: March 19, 2022

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2).

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2).

Journal: Journal of hematology & oncology

Published: March 11, 2022

Effects of conventional interventions on early-stage primary cutaneous marginal zone lymphoma: A population-based study.

Effects of conventional interventions on early-stage primary cutaneous marginal zone lymphoma: A population-based study.

Journal: Leukemia research

Published: January 11, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026